May 01, 2019 - GlaxoSmithKline plc (NYSE:GSK) Q1 2019 Earnings Conference Call May 01, 2019 09:00 AM ET Company Participants Sarah Elton-Farr - Head, Investor Relations Emma Walmsley - Chief Executive Officer Iain M
May 01, 2019 - Allergan's (AGN) key products like Botox are likely to provide top-line support in Q1 as loss of exclusivity of several products hurts sales
Apr 30, 2019 - ANI Pharmaceuticals (ANIP) will provide updates on product launches, when it releases first-quarter 2019 results.
Apr 30, 2019 - BioSpecifics Technologies (BSTC) will provide updates on Xiaflex and pipeline progress, when it releases first-quarter 2019 results.
Apr 29, 2019 - Pricing erosion in U.S. generics market and rapid erosion in sales of Copaxone are likely to hurt Teva's (TEVA) sales in Q1.
Apr 26, 2019 - Strong sales of Glaxo's (GSK) Vaccines segment is likely to drive the top line in the first quarter.
Apr 24, 2019 - Novartis (NVS) beats on Q1 earnings, sales marginally miss estimates.
Apr 23, 2019 - Investors are looking forward to Revlimid's performance and updates on the impending acquisition agreement with Bristol-Myers, when Celgene Corporation (CELG) reports Q1 results.
Apr 23, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Apr 22, 2019 - Bayer (BAYRY) is expected to provide pipeline updates along with its first-quarter results.